• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间期结肠癌的遗传机制。

Genetic mechanisms in interval colon cancers.

机构信息

GRJ 704, Gastrointestinal Unit, Massachusetts General Hospital, 50 Blossom Street, Boston, MA, 02114, USA,

出版信息

Dig Dis Sci. 2014 Sep;59(9):2255-63. doi: 10.1007/s10620-014-3134-2. Epub 2014 Apr 5.

DOI:10.1007/s10620-014-3134-2
PMID:24705641
Abstract

BACKGROUND AND AIM

The factors underlying the development of interval colon cancers are not well defined and are likely heterogeneous. We sought to determine whether there are distinct molecular properties associated with interval colon cancers.

METHODS

Colon cancers diagnosed within 5 years of a complete and well-prepped colonoscopic examination were identified over a 7-year period at a single institution. The clinical and pathological features of the tumors were defined. Analysis of DNA mismatch repair (MMR) and genotyping of a panel of oncogenes associated with colon cancer were performed.

RESULTS

Forty-two interval colon cancers were diagnosed at an average age of 70 years. 69 % of tumors were located in the right colon. 41 % of tumors exhibited DNA microsatellite instability (MSI). Loss of staining of DNA MMR proteins by immunohistochemistry (IHC) was confirmed in 82 % of the MSI-positive tumors. Among tumors with abnormal MSI and IHC, 54 % exhibited somatic methylation of the MLH1 promoter, but the remaining 43 % exhibited molecular features indicative of underlying Lynch syndrome (LS). The frequency of somatic mutations in the KRAS, BRAF, NRAS, and PIK3CA oncogenes was similar between interval cancer cases and controls.

CONCLUSIONS

Interval colon cancers are not distinguished by the activation of the KRAS, NRAS, BRAF, or PIK3CA oncogenic pathways. However, MSI pathway defects are present in a significant proportion of interval colon cancers. Underlying LS may explain nearly half of these MSI-positive cases, and the remaining cases appear to represent sporadic serrated pathway tumors.

摘要

背景与目的

导致间期结肠癌发生的因素尚不清楚,而且可能具有异质性。我们试图确定是否存在与间期结肠癌相关的独特分子特征。

方法

在单个机构的 7 年期间,鉴定了在完全且准备充分的结肠镜检查后 5 年内诊断出的结肠癌。定义了肿瘤的临床和病理特征。对 DNA 错配修复(MMR)进行分析,并对与结肠癌相关的一组癌基因进行基因分型。

结果

42 例间期结肠癌在平均年龄为 70 岁时被诊断出来。69%的肿瘤位于右结肠。41%的肿瘤表现出 DNA 微卫星不稳定性(MSI)。免疫组化(IHC)证实 82%的 MSI 阳性肿瘤中存在 DNA MMR 蛋白染色丢失。在异常 MSI 和 IHC 的肿瘤中,54%表现出 MLH1 启动子的体细胞甲基化,但其余 43%表现出潜在林奇综合征(LS)的分子特征。KRAS、BRAF、NRAS 和 PIK3CA 癌基因的体细胞突变频率在间期癌病例和对照之间相似。

结论

间期结肠癌不能通过 KRAS、NRAS、BRAF 或 PIK3CA 致癌途径的激活来区分。然而,MSI 途径缺陷存在于相当一部分间期结肠癌中。潜在的 LS 可能解释了近一半的这些 MSI 阳性病例,而其余病例似乎代表散发性锯齿状途径肿瘤。

相似文献

1
Genetic mechanisms in interval colon cancers.间期结肠癌的遗传机制。
Dig Dis Sci. 2014 Sep;59(9):2255-63. doi: 10.1007/s10620-014-3134-2. Epub 2014 Apr 5.
2
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes.分子标志物可识别与患者预后相关的III期结肠癌亚型。
Gastroenterology. 2015 Jan;148(1):88-99. doi: 10.1053/j.gastro.2014.09.041. Epub 2014 Oct 8.
3
Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.散发性微卫星高度不稳定的结肠癌很少表现出Wnt信号激活的免疫组化证据。
Am J Surg Pathol. 2015 Mar;39(3):313-7. doi: 10.1097/PAS.0000000000000380.
4
The mechanisms underlying MMR deficiency in immunodeficiency-related non-Hodgkin lymphomas are different from those in other sporadic microsatellite instable neoplasms.免疫缺陷相关非霍奇金淋巴瘤中错配修复缺陷的潜在机制与其他散发性微卫星不稳定肿瘤中的机制不同。
Int J Cancer. 2009 Nov 15;125(10):2360-6. doi: 10.1002/ijc.24681.
5
[Immunohistochemical examination of MSH2, PMS2, MLH1, MSH6 compared with the analysis of microsatellite instability in colon adenocarcinoma].[与结肠腺癌微卫星不稳定性分析相比,MSH2、PMS2、MLH1、MSH6的免疫组织化学检查]
Vopr Onkol. 2014;60(2):47-50.
6
Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?早发性 MSI-H 结直肠癌伴 MLH1 启动子甲基化,是否存在遗传易感性?
BMC Cancer. 2010 May 5;10:180. doi: 10.1186/1471-2407-10-180.
7
Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors.难治性生殖细胞肿瘤中的微卫星不稳定性、错配修复缺陷和BRAF突变
J Clin Oncol. 2009 May 1;27(13):2129-36. doi: 10.1200/JCO.2008.18.8623. Epub 2009 Mar 16.
8
High-level microsatellite instability in appendiceal carcinomas.阑尾腺癌中高水平微卫星不稳定。
Am J Surg Pathol. 2013 Aug;37(8):1192-200. doi: 10.1097/PAS.0b013e318282649b.
9
Molecular characterization of endometrial cancer: a correlative study assessing microsatellite instability, MLH1 hypermethylation, DNA mismatch repair protein expression, and PTEN, PIK3CA, KRAS, and BRAF mutation analysis.子宫内膜癌的分子特征:一项评估微卫星不稳定性、MLH1 高甲基化、DNA 错配修复蛋白表达以及 PTEN、PIK3CA、KRAS 和 BRAF 突变分析的相关性研究。
Int J Gynecol Pathol. 2012 May;31(3):195-205. doi: 10.1097/PGP.0b013e318231fc51.
10
KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients.中国结直肠癌患者的KRAS和BRAF基因突变及DNA错配修复状态
World J Gastroenterol. 2015 Feb 7;21(5):1595-605. doi: 10.3748/wjg.v21.i5.1595.

引用本文的文献

1
Mucin 5AC as a Biomarker for Sessile Serrated Lesions: Results From a Systematic Review and Meta-Analysis.黏蛋白5AC作为无蒂锯齿状病变的生物标志物:系统评价和荟萃分析结果
Clin Transl Gastroenterol. 2025 May 1;16(5):e00831. doi: 10.14309/ctg.0000000000000831.
2
Clinicopathological and molecular differences between stage IV screen-detected and interval colorectal cancers in the Flemish screening program.弗拉芒筛查项目中IV期筛查发现的结直肠癌与间期结直肠癌之间的临床病理及分子差异
Front Oncol. 2024 Sep 2;14:1409196. doi: 10.3389/fonc.2024.1409196. eCollection 2024.
3
Patient and Endoscopic Characteristics of Postcolonoscopy Colon Cancer-A Case-control Study.

本文引用的文献

1
Prevention of interval colorectal cancers: what every clinician needs to know.预防结直肠癌间期癌:每个临床医生都需要知道的事。
Clin Gastroenterol Hepatol. 2014 Jan;12(1):7-15. doi: 10.1016/j.cgh.2013.04.027. Epub 2013 Apr 29.
2
Cancer statistics, 2013.癌症统计数据,2013 年。
CA Cancer J Clin. 2013 Jan;63(1):11-30. doi: 10.3322/caac.21166. Epub 2013 Jan 17.
3
Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study.结肠镜检查中不完全息肉切除术-完整腺瘤切除术(CARE)研究结果。
结肠镜检查后结肠癌的患者及内镜特征——一项病例对照研究
Gastro Hep Adv. 2022 Mar 30;1(3):277-286. doi: 10.1016/j.gastha.2022.01.001. eCollection 2022.
4
Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing.通过靶向二代测序分析突变作为大肠锯齿状息肉复发的潜在预测指标
Front Oncol. 2022 Mar 23;12:769709. doi: 10.3389/fonc.2022.769709. eCollection 2022.
5
Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective.从“间期癌”角度优化比利时佛兰德斯的粪便免疫化学试验(FIT)结直肠癌筛查方案。
Br J Cancer. 2022 Apr;126(7):1091-1099. doi: 10.1038/s41416-021-01694-2. Epub 2022 Jan 12.
6
Future Prospects of Colorectal Cancer Screening: Characterizing Interval Cancers.结直肠癌筛查的未来前景:间隔期癌症的特征分析
Cancers (Basel). 2021 Mar 16;13(6):1328. doi: 10.3390/cancers13061328.
7
Clinical Features and Genomic Characterization of Post-Colonoscopy Colorectal Cancer.结肠镜检查后结直肠癌的临床特征和基因组特征。
Clin Transl Gastroenterol. 2020 Oct;11(10):e00246. doi: 10.14309/ctg.0000000000000246.
8
Characterizing Microsatellite Instability and Chromosome Instability in Interval Colorectal Cancers.描述间期结直肠癌中的微卫星不稳定性和染色体不稳定性。
Neoplasia. 2018 Sep;20(9):943-950. doi: 10.1016/j.neo.2018.07.007. Epub 2018 Aug 15.
9
Clinical characteristics of synchronous colorectal cancers in Japan.日本同时性结直肠癌的临床特征
World J Surg Oncol. 2016 Oct 24;14(1):272. doi: 10.1186/s12957-016-1027-x.
10
Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.结肠镜检查后结直肠癌的临床和分子特征:一项基于人群的研究。
Gastroenterology. 2016 Nov;151(5):870-878.e3. doi: 10.1053/j.gastro.2016.07.010. Epub 2016 Jul 19.
Gastroenterology. 2013 Jan;144(1):74-80.e1. doi: 10.1053/j.gastro.2012.09.043. Epub 2012 Sep 25.
4
Risk and cause of interval colorectal cancer after colonoscopic polypectomy.结肠镜息肉切除术后结直肠癌的风险和病因。
Digestion. 2012;86(2):148-54. doi: 10.1159/000338680. Epub 2012 Aug 8.
5
Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.结肠镜息肉切除术与结直肠癌死亡的长期预防。
N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.
6
Is KRAS mutation associated with interval colorectal cancers?KRAS 突变与结直肠间期癌是否相关?
Dig Dis Sci. 2012 Apr;57(4):913-7. doi: 10.1007/s10620-011-1974-6. Epub 2011 Dec 3.
7
Clinicopathologic and molecular profiles of microsatellite unstable Barrett Esophagus-associated adenocarcinoma.微卫星不稳定的 Barrett 食管相关腺癌的临床病理和分子特征。
Am J Surg Pathol. 2011 May;35(5):647-55. doi: 10.1097/PAS.0b013e31820f18a2.
8
Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer.结直肠癌中 KRAS、BRAF 和 NRAS 基因突变的频率。
Genes Chromosomes Cancer. 2011 May;50(5):307-12. doi: 10.1002/gcc.20854. Epub 2011 Feb 8.
9
Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.快速靶向突变分析人类肿瘤:指导个体化癌症治疗的临床平台。
EMBO Mol Med. 2010 May;2(5):146-58. doi: 10.1002/emmm.201000070.
10
Role of the serrated pathway in colorectal cancer pathogenesis.锯齿状通路在结直肠癌发病机制中的作用。
Gastroenterology. 2010 Jun;138(6):2088-100. doi: 10.1053/j.gastro.2009.12.066.